A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer. Studies show it extends survival, slows disease progression, shrinks ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Chemotherapy drugs for brain tumors typically haven’t been able to get past the blood-brain barrier, says Duke ...

CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their cancer worsening and a shorter but equally effective treatment for a ...

CAR-T therapy is a highly specialized treatment that requires careful patient selection and close monitoring. Some patients ...

Lehi, Utah, April 16, 2026 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced ...

Every year, tens of thousands of the world's leading cancer researchers descend on Chicago carrying with them the hopes of ...

Dr. Ravi Patel joins us for his monthly update from the Comprehensive Blood & Cancer Center (CBCC). Dr. Patel talked with us about a major breakthrough in the world of cancer research, the biopsy ...

More than 150,000 Americans will be diagnosed with colorectal cancer this year. Around the globe, hundreds of thousands more ...